Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch

Recruiting now

Conditions studied: Cancer, Emergencies

In brief

The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.

Key facts

Study ID

NCT06680778

Run by

Erasmus Medical Center

People needed

175

Starts

2025-07-01

Expected to finish

2025-12-31

Last updated by the study team

2025-08-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years;
• Diagnosis of stomach or esophageal cancer with an indication of starting chemotherapy
• Knowledge how to handle a Fitbit
• Mastery of Dutch language
• Able and willing to give written informed consent

You may not qualify if…

• Cognitive disorders or severe emotional instability
• Already participating in an exercise trial

Where it is running

• Erasmus University Medical Center — Rotterdam, South Holland, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.